Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Tanner

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Tuberculosis (Edinburgh, Scotland)|December 6, 2018
Meeting report: 5th Global Forum on TB Vaccines, 20-23 February 2018, New Delhi IndiaKrishnamohan Atmakuri, Adam Penn-Nicholson, Rachel Tanner, et al.
Journal of Infection and Public Health|June 21, 2023
Determinants of COVID-19 immunisation uptake in a country with high mortality and a low vaccination rateDunja Aksentijevic, Rachel Tanner, Lejla Lazović-Pita, et al.
Frontiers in Immunology|February 21, 2024
Development and application of the direct mycobacterial growth inhibition assay: a systematic reviewHannah Painter, Eli Harriss, Helen A Fletcher, et al.
Vaccine|March 2, 2025
Workshop report: One Health challenges and knowledge gaps in the control of intracellular infections with a focus on tuberculosis and leishmaniasisMichele Miller, Maria Adelaida Gómez, Rachel Tanner, et al.
Tuberculosis (Edinburgh, Scotland)|February 17, 2024
Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strainsHannah Painter, Sam Willcocks, Andrea Zelmer, et al.
Tuberculosis (Edinburgh, Scotland)|August 14, 2017
A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine developmentIlaria Pepponi, Bhagwati Khatri, Rachel Tanner, et al.
Frontiers in Immunology|October 24, 2022
Chronovaccination: Harnessing circadian rhythms to optimize immunisation strategiesClaire O Otasowie, Rachel Tanner, David W Ray, et al.
Frontiers in Immunology|October 23, 2025
Functional and phenotypic characterization of peripheral blood mononuclear cells from tuberculosis patients in Southern ThailandPyae Sone Oo, Jomkwan Ongarj, Ratchanon Sophonmanee, et al.
Immunology|June 19, 2025
Acute Plasmodium yoelii 17XNL Infection During BCG Vaccination Limits T Cell Responses and Mycobacterial Growth InhibitionEmily Tangie, Nawamin Pinpathomrat, Rachel Tanner, et al.
Scientific Reports|February 26, 2020
Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cellsHannah Painter, Satria A Prabowo, Felipe Cia, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Tuberculosis (Edinburgh, Scotland)|December 6, 2018
Meeting report: 5th Global Forum on TB Vaccines, 20-23 February 2018, New Delhi IndiaKrishnamohan Atmakuri, Adam Penn-Nicholson, Rachel Tanner, et al.
Journal of Infection and Public Health|June 21, 2023
Determinants of COVID-19 immunisation uptake in a country with high mortality and a low vaccination rateDunja Aksentijevic, Rachel Tanner, Lejla Lazović-Pita, et al.
Frontiers in Immunology|February 21, 2024
Development and application of the direct mycobacterial growth inhibition assay: a systematic reviewHannah Painter, Eli Harriss, Helen A Fletcher, et al.
Vaccine|March 2, 2025
Workshop report: One Health challenges and knowledge gaps in the control of intracellular infections with a focus on tuberculosis and leishmaniasisMichele Miller, Maria Adelaida Gómez, Rachel Tanner, et al.
Tuberculosis (Edinburgh, Scotland)|February 17, 2024
Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strainsHannah Painter, Sam Willcocks, Andrea Zelmer, et al.
Tuberculosis (Edinburgh, Scotland)|August 14, 2017
A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine developmentIlaria Pepponi, Bhagwati Khatri, Rachel Tanner, et al.
Frontiers in Immunology|October 24, 2022
Chronovaccination: Harnessing circadian rhythms to optimize immunisation strategiesClaire O Otasowie, Rachel Tanner, David W Ray, et al.
Frontiers in Immunology|October 23, 2025
Functional and phenotypic characterization of peripheral blood mononuclear cells from tuberculosis patients in Southern ThailandPyae Sone Oo, Jomkwan Ongarj, Ratchanon Sophonmanee, et al.
Immunology|June 19, 2025
Acute Plasmodium yoelii 17XNL Infection During BCG Vaccination Limits T Cell Responses and Mycobacterial Growth InhibitionEmily Tangie, Nawamin Pinpathomrat, Rachel Tanner, et al.
Scientific Reports|February 26, 2020
Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cellsHannah Painter, Satria A Prabowo, Felipe Cia, et al.
Pageof 8